Analysis of the Effects of the Bruton's tyrosine kinase (Btk) Inhibitor Ibrutinib on Monocyte Fcγ Receptor (FcγR) Function

Abstract
No abstract available
Funding Information
  • National Institutes of Health (P01-CA095426, R01 CA162411, R01 CA177292, R01 CA183444, T32 HL007946)

This publication has 55 references indexed in Scilit: